| RNPHX | VEOAX | RNPHX / VEOAX | |
| Total Expense Ratio | 0.55 | 0.55 | 100% |
| Annual Report Gross Expense Ratio | 0.55 | 0.55 | 100% |
| Fund Existence | 11 years | 4 years | - |
| Gain YTD | 7.622 | 12.326 | 62% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 50000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 166B | 132M | 125,758% |
| Annual Yield % from dividends | 1.12 | 1.01 | 111% |
| Returns for 1 year | 7.28 | 17.01 | 43% |
| Returns for 3 years | 41.05 | 33.20 | 124% |
| Returns for 5 years | 11.32 | N/A | - |
| Returns for 10 years | 107.09 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HFYCX | 16.54 | 0.04 | +0.24% |
| Hartford Schroders Intl Multi-Cp Val C | |||
| SMNIX | 29.40 | 0.04 | +0.14% |
| Steward Equity Market Neutral I | |||
| VISGX | 98.24 | -0.02 | -0.02% |
| Vanguard MStar Small Cap Growth Indx Inv | |||
| FBTDX | 182.34 | -0.66 | -0.36% |
| Franklin Biotechnology Discovery C | |||
| CCGSX | 29.91 | -0.16 | -0.53% |
| Baird Chautauqua Global Growth Inv | |||